Related Experiment Video
Updated: Dec 22, 2025

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review
1Alliance for Benzodiazepine Best Practices, Littleton, CO, USA. sleighwright@gmail.com.
Benzodiazepine receptor agonists (BZRAs) offer limited analgesic benefits for specific pain conditions. Their use in pain management should be restricted due to potential dependence and loss of efficacy, with careful tapering recommended for long-term users.
Area of Science:
- Pharmacology
- Pain Management
- Neurology
Background:
- Controversy surrounds the use of benzodiazepine receptor agonists (BZRAs) in pain management.
- This review aims to clarify the appropriate role of BZRAs in pain treatment.
- Challenges in BZRAs' application for pain require careful consideration by prescribers.
Purpose of the Study:
- To determine the appropriate role of BZRAs in pain management.
- To develop practice recommendations for BZRAs in pain management.
- To address challenges associated with BZRAs in pain management.
Main Methods:
- A narrative review of available research was conducted.
- Publications were identified through PubMed, reference lists, guidelines, and personal files.
- The review focused on determining the efficacy and appropriate use of BZRAs in pain management.
Main Results:
- BZRAs demonstrated analgesic benefits for burning mouth syndrome and stiff person syndrome.
- Efficacy for other pain conditions could not be concluded due to limited research and small sample sizes.
- BZRAs may help with co-occurring insomnia and anxiety but should be used short-term (2-4 weeks) and only when alternatives are inadequate.
Conclusions:
- BZRAs are often inappropriately used in pain management and their use should be limited to specific conditions.
- Loss of efficacy and adverse effects, including dependence (20-100% with >1 month use), limit BZRAs' utility.
- Discontinuation of BZRAs prescribed for 4 weeks or more should involve a slow, supported tapering process (12-18+ months).
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Analgesia and Pain Management
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Barbiturates
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...

